États-Unis · Plateformes & données · MarketBeat

Bioventus Q3 Earnings Call Highlights

Publié par MarketBeat · États-Unis il y a 3 h

Bioventus (NASDAQ:BVS) reported third-quarter revenue growth of 3% as strength in its Pain Treatments business, Ultrasonics operation and international markets was partly offset…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Bioventus Q3 Earnings Call Highlights

À lire aussi

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

Why Keel Infrastructure Stock Got Mashed on Monday

Apple’s iPhone business is booming. Here’s why the stock is falling anyway.

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

UBS MSCI World Selection UCITS ETF hEUR acc CSY7 ETF Analysis

Bioventus Q3 Earnings Call Highlights

Partager

À lire aussi

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

Why Keel Infrastructure Stock Got Mashed on Monday

Apple’s iPhone business is booming. Here’s why the stock is falling anyway.

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

UBS MSCI World Selection UCITS ETF hEUR acc CSY7 ETF Analysis